Novel thieno oxazine analogues as antihyperglycemic and lipid modulating agents

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 3, 2003, Pages 399-403

  Das, Saibal Kumar ^a   Reddy, K Anantha ^a   Abbineni, Chandrasekhar ^a   Iqbal, Javed ^a   Suresh, J ^a   Premkumar, M ^a   Chakrabarti, Ranjan ^a  

^a DR REDDY S RESEARCH FOUNDATION   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; GLUCOSE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHENYLACETIC ACID DERIVATIVE; PROPIONIC ACID DERIVATIVE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; DRUG SYNTHESIS; GLUCOSE BLOOD LEVEL; MOUSE; NONHUMAN; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; ANTILIPEMIC AGENTS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DRUG DESIGN; HYPOGLYCEMIC AGENTS; INDICATORS AND REAGENTS; MAGNETIC RESONANCE SPECTROSCOPY; MICE; OXAZINES; PROPIONIC ACIDS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SPECTROPHOTOMETRY, INFRARED; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTION FACTORS; TRIGLYCERIDES;

EID: 0037330394     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(02)00976-9     Document Type: Article

References (30)

1. Reaven G.M. Diabetes. 37:1988;1597.
2. (a) Epstein, M.; Sowers, J. R. Hypertension 1992, 19, 403.
3. (b) Landsberg, L. Hypertension 1992, 19(Suppl. 1), 161.
4. Lehman J.M., Moore L.B., Oliver-Smith T.A., Wilkinson T.M., Kilewer S.A. J. Biol. Chem. 270:1995;12953.
5. (a) Larson, E. R.; Clark, D. A.; Stevenson, R. W. Ann. Reports Med. Chem. 1989, 25, 205.
6. (b) Colca, J. R.; Tanis, S. P. Ann. Reports Med. Chem. 1992, 27, 219.
7. (c) Dow, R. L.; Kreutter, D. K. Ann. Reports Med. Chem. 1995, 30,159.
8. Scrip 1998, 20, 2342.
9. (a) Idzior-Walus, B.; Sieradzki, J.; Rostworowski, W.; Zdzienicka, A.; Kawalec, E.; Wójcik, J.; Arnecki, A. Z.; Blane, G. Eur. J. Clin. Invest. 2000, 30, 871.
10. (b) Kockx, M.; Gervois, P. P.; Poulain, P.; Derudas, B.; Peters, J. M.; Gonzalez, F. J.; Pribcen, H. M. G.; Kooistra, T.; Staels, B. Blood 1999, 93, 2991.
11. (c) Staels, B.; Dallongeville, J.; Auwerx, J.; Schoonjans, K.; Leitersdorf, E.; Fruchart, J.-C. Circulation 1998, 98, 2088.
12. (d) Gaw, A.; Packard, C. J.; Shepherd, J. Handbook of Experimental Pharmacology; Springer-Verlag: Berlin, 1994; Vol. 109, p 325.
13. Scrip 2001, 23, 2668.
14. Ogawa S., Takeuchi K., Sugimura K., Fukuda M., Lee R., Ito S., Sato T. Metabolism. 49:2000;331.
15. (a) Shimokawa, T.; Nishijima, S.; Matsuda, K.; Iizumi, Y.; Hashimoto, S. PCT Patent WO 9904815, 1999; Chem. Abstr. 1999, 130, 163186.
16. (b) Adams, A. D.; Berger, G. D.; Bergman, J. P.; Berger, J. P.; Han, W.; Leibowitz, M. D.; Moller, D. E.; Santini, C.; Sahoo, S.; Tolman, R. L.; Young, J. R. PCT Patent WO 9727857, 1997; Chem. Abstr. 1998, 127, 205352.
17. (c) Adams, A. D.; Berger, J. P.; Berger, G. D.; Fitch, K. J.; Graham, D. W.; Jones, A. B.; Von Largen, D.; Leibowitz, M. D.; Moller, D. E.; Patechett, A. A.; Sahoo, S. P.; Tolman, R. L.; Toupence, R. B.; Walsh, T. F. PCT Patent WO 9728137, 1997; Chem. Abstr. 1998, 127, 220650.
18. (a) Lohray, B. B.; Lohray, V. B.; Bajji, A. C.; Kalchar, S.; Poondra, R. R.; Padakanti, S.; Chakrabarti, R.; Vikramadithyan, R. K., Misra, P.; Juluri, S.; Mamidi, N. V. S. R.; Rajagopalan, R. J. Med. Chem. 2001, 44, 2675.
19. (b) Dahllöf, B.; Östling, J.; Wettesten, M.; Larsson, L.-O.; Alexandersson, M.; Lindstedt, E.-L.; Karlsson, U.; Bamberg, K. Diabetes 2001, 50 (Suppl. 2): Abstr. No. P488.
20. Watanabe S., Ogawa K., Ohno T., Yano S., Yamada H., Shirasaka T. Eur. J. Med. Chem. 29:1994;675.
21. Erker T. Monatsch Chem. 129:1998;679.
22. +=391.
23. (a) Lohray, B. B.; Bhushan, B.; Rao, B. P.; Madhavan, G. R.; Murali, N.; Rao, K. N.; Reddy, A. K.; Rajesh, B. M.; Reddy, P. G.; Chakrabarti, R.; Vikramadithyan, R. K.; Rajagopalan, R., Mamidi, R. N. V. S.; Jajoo, H. K.; Subramaniam, S. J. Med. Chem. 1998, 41, 1619.
24. (b) Shimokawa, T.; Nishijima, S.; Matsuda, K.; Iizumi, Y.; Hashimoto, S. WO Patent 9904815, 1999; Chem. Abstr. 1999, 130, 163186.
25. (c) Madhavan G.R., Chakrabarti R., Kumar S.K.B., Misra P., Mamidi R.N.V.S., Balaraju V., Kasiram K., Babu R.K., Suresh J., Lohray B.B., Lohray V.B., Iqbal J., Rajagopalan R. Eur. J. Med. Chem. 36:2001;627.
26. Ethyl 3-[4-(2-bromoethoxy)phenyl]-2-ethoxypropanoate prepared as disclosed in Lohray, B. B.; Lohray, V. B.; Bajji, A. C.; Kalchar, S.; Rajagopalan, R.; Chakrabarti, R. US Patent 6054453, 2000; Chem. Abstr. 2000, 132, 293769b.
27. Herberg L., Coleman D.L. Metabolism. 26:1977;59.
28. Madhavan G.R., Chakrabarti R., Vikramadithyan R.K., Mamidi R.N.V.S., Balaraju V., Rajesh B.M., Misra P., Kumar S.K.B., Lohray B.B., Lohray V.B., Rajagopalan R. Bioorg. Med. Chem. 10:2002;2671. and references cited therein.
29. 19 was applied.
30. Reddy K.A., Lohray B.B., Lohray V.B., Reddy A.S., Mamidi N.V.S.R., Reddy P.P., Saibaba V., Reddy N.J., Suryaprakash A., Misra P., Vikramadithyan R.K., Rajagopalan R. J. Med. Chem. 42:1999;3265. and references cited therein.